Skip to main content
Erschienen in: Clinical Research in Cardiology 5/2024

15.04.2024 | Original Paper

The role of cardiac magnetic resonance in sports cardiology: results from a large cohort of athletes

verfasst von: Viviana Maestrini, Marco Penza, Sara Monosilio, Cristian Borrazzo, Silvia Prosperi, Domenico Filomena, Lucia Ilaria Birtolo, Erika Lemme, Ruggiero Mango, Giuseppe Di Gioia, Gianfranco Gualdi, Maria Rosaria Squeo, Antonio Pelliccia

Erschienen in: Clinical Research in Cardiology | Ausgabe 5/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Cardiac magnetic resonance (CMR) provides information on morpho-functional abnormalities and myocardial tissue characterisation. Appropriate indications for CMR in athletes are uncertain.

Objective

To analyse the CMR performed at our Institute to evaluate variables associated with pathologic findings in a large cohort of athletes presenting with different clinical conditions.

Methods

All the CMR performed at our Institute in athletes aged > 14 years were recruited. CMR indications were investigated. CMR was categorised as “positive” or “negative” based on the presence of morphological and/or functional abnormalities and/or the presence of late gadolinium enhancement (excluding the right ventricular insertion point), fat infiltration, or oedema. Variables associated with “positive” CMR were explored.

Results

A total of 503 CMR were included in the analysis. “Negative” and “positive” CMR were 61% and 39%, respectively. Uncommon ventricular arrhythmias (VAs) were the most frequent indications for CMR, but the proportion of positive results was low (37%), and only polymorphic ventricular patterns were associated with positive CMR (p = 0.006). T-wave inversion at 12-lead ECG, particularly on lateral and inferolateral leads, was associated with positive CMR in 34% of athletes (p = 0.05). Echocardiography abnormalities resulted in a large proportion (58%) of positive CMR, mostly cardiomyopathies.

Conclusion

CMR is more efficient in identifying a pathologic cardiac substrate in athletes in case of VAs (i.e., polymorphic beats), abnormal ECG repolarisation (negative T-waves in inferolateral leads), and borderline echocardiographic findings (LV hypertrophy, mildly depressed LV function). On the other hand, CMR is associated with a large proportion of negative results. Therefore, a careful clinical selection is needed to indicate CMR in athletes appropriately.

Graphical Abstract

Clinical indications for CMR and positive CMR findings.
The left panel shows clinical indications for CMR in our athletic cohort and the percentage of negative CMRs. In contrast, the right one shows the percentages of positive CMR findings with some examples. The white arrows in the right panel show an ARVD with a dilated right ventricle and multiple aneurysms of its free wall. The red arrows show the distribution of LGE in the left ventricle. The red panel below shows indications associated with positive CMR findings. ARVD, arrhythmogenic right ventricular disease; BAV, bicuspid aortic valve; CMP, cardiomyopathies; CMR, cardiac magnetic resonance; DCM, dilated cardiomyopathy; ECG, electrocardiogram; Echo, echocardiogram; FHx, family history; HCM, hypertrophic cardiomyopathy; LAD, left axis deviation; LBBB, left bundle branch block; LGE, late gadolinium enhancement; LV, left ventricle; LVH, left ventricular hypertrophy; LVNC, left ventricular non-compaction; MVP, mitral valve prolapse; RV, right ventricle; SVAs, supraventricular arrhythmias; VAs, ventricular arrhythmias; VHD, valvular heart diseases; TWI, T-wave inversion.
Literatur
6.
Zurück zum Zitat Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219. https://doi.org/10.1093/EURHEARTJ/EHT151CrossRefPubMed Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219. https://​doi.​org/​10.​1093/​EURHEARTJ/​EHT151CrossRefPubMed
11.
Zurück zum Zitat Pelliccia A, Caselli S, Sharma S et al (2018) European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement: recommendations for the indication and interpretation of cardiovascular imaging in the evaluation of the athlete’s heart. Eur Heart J 39:1949–1969. https://doi.org/10.1093/EURHEARTJ/EHX532CrossRefPubMed Pelliccia A, Caselli S, Sharma S et al (2018) European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement: recommendations for the indication and interpretation of cardiovascular imaging in the evaluation of the athlete’s heart. Eur Heart J 39:1949–1969. https://​doi.​org/​10.​1093/​EURHEARTJ/​EHX532CrossRefPubMed
12.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–271. https://doi.org/10.1093/EHJCI/JEV014CrossRefPubMed Lang RM, Badano LP, Mor-Avi V et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 16:233–271. https://​doi.​org/​10.​1093/​EHJCI/​JEV014CrossRefPubMed
15.
Zurück zum Zitat Messroghli DR, Moon JC, Ferreira VM, et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19. https://doi.org/10.1186/S12968-017-0389-8 Messroghli DR, Moon JC, Ferreira VM, et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19. https://​doi.​org/​10.​1186/​S12968-017-0389-8
Metadaten
Titel
The role of cardiac magnetic resonance in sports cardiology: results from a large cohort of athletes
verfasst von
Viviana Maestrini
Marco Penza
Sara Monosilio
Cristian Borrazzo
Silvia Prosperi
Domenico Filomena
Lucia Ilaria Birtolo
Erika Lemme
Ruggiero Mango
Giuseppe Di Gioia
Gianfranco Gualdi
Maria Rosaria Squeo
Antonio Pelliccia
Publikationsdatum
15.04.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 5/2024
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-024-02447-w

Weitere Artikel der Ausgabe 5/2024

Clinical Research in Cardiology 5/2024 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.